Bloomios, Inc.
BLMS · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.01 | 0.03 | -0.01 |
| FCF Yield | -1,414.51% | 8.22% | -2.56% | -42.71% |
| EV / EBITDA | -0.98 | -19.43 | -27.75 | -4.07 |
| Quality | ||||
| ROIC | 9.30% | -7.42% | -8.22% | -6.67% |
| Gross Margin | 46.29% | 30.87% | 24.51% | 11.22% |
| Cash Conversion Ratio | 0.04 | -0.05 | 0.19 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.78% | 2.84% | -3.00% | 1.11% |
| Free Cash Flow Growth | -1,107.66% | 121.96% | 90.42% | -2,028.87% |
| Safety | ||||
| Net Debt / EBITDA | -0.98 | -18.37 | -15.02 | -2.59 |
| Interest Coverage | -0.79 | -1.49 | -1.54 | -0.21 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 1.11 | 1.18 | 1.06 |
| Cash Conversion Cycle | -818.78 | -63.30 | -25.28 | -4.92 |